National Institutes of Health Office of Research on Women’s Health
Presentation Abstract
Roundtable on Elevating Patient-Centered Strategies for Care
In this roundtable, we are elevating the voice of patients, families, and providers regarding patient-centered strategies for care. Patients who experience severe maternal morbidity are at greatest risk of mortality. Their personal experience of severe complications during pregnancy or postpartum may result in long-term suffering, which may be worsened by the care they received, especially when it was not centered on their needs and desires. Maternal morbidity and mortality also has a lasting effect on families, as alongside every individual who is severely affected or lost during or after pregnancy is a family unit.
About Dr. Stratton
Dr. Pamela Stratton serves as the Obstetrician-Gynecologist Physician Lead at the Office of Research on Women’s Health (ORWH). After a 30-year career in the U.S. Public Health Service (USPHS) where she conducted clinical research across broad topics in obstetrics and gynecology from preventing mother-to-child transmission of HIV to developing new contraceptive methods to developing novel treatments for pain from endometriosis to studying the gynecologic and reproductive health in women with complex and rare diseases, she joined ORWH. As the ORWH co-lead on this postpartum maternal health Pathways to Prevention project, she combines her expertise in maternal health and obstetrics with her experience fostering NIH-wide collaborations. During her tenure as head of the NIH Clinical Center Gynecology Consult Service from 2000–2016, she conducted innovative, translational gynecology research and tackled urgent and important concerns impacting on the participation of women across clinical research protocols, balancing the health of women with the research goals. As the first woman Chair of the NIH Clinical Center Surgical Administrative Committee, she was recognized with a Distinguished Service Medal from the USPHS. She has authored over 200 papers and is known internationally for her research in AIDS, contraceptive development, improving understanding and treatments of endometriosis-related pain, and women undergoing stem cell transplantation especially for genital graft-versus-host disease and human papillomavirus (HPV) disease. She is known for her gynecologic expertise in women with aplastic anemia, Fanconi Anemia, Dyskeratosis congenita, Hereditary Leiomyoma and Renal Cell Cancer, von Hippel Lindau disease, DICER1 syndrome, GATA2 deficiency, WHIM syndrome, inherited lipodystrophies, and HPV disease in immunocompromised women.